PetCaseFinder

Peer-reviewed veterinary case report

Antibiotic-resistant E coli causing dog urinary infections in Canada

By Courtice, Rachel et al.·Published in Journal of veterinary internal medicine·2021·Department of Veterinary Microbiology, Canada·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Characterization of antimicrobial-resistant Escherichia coli causing urinary tract infections in dogs: Passive surveillance in Saskatchewan, Canada 2014 to 2018.

Species:
dog

Plain-English summary

A study looked at urine samples from 516 dogs in Saskatchewan to understand how common antibiotic-resistant E. coli bacteria are in urinary tract infections (UTIs). The good news is that about 80% of the bacteria were still sensitive to standard treatments, meaning most dogs can be effectively treated with first-line antibiotics. However, nearly 15% of the samples showed resistance to ampicillin, a common antibiotic. This research highlights the importance of monitoring antibiotic resistance in pets, especially since one strain identified is known to be more concerning.

People also search for: dog urinary tract infection treatment · antibiotic resistance in dogs · E. coli UTI symptoms in dogs

Abstract

BACKGROUND: Urinary tract infections (UTIs) are common in dogs and can be caused by multidrug-resistant Escherichia coli (E coli). OBJECTIVE: To describe the frequency and mechanisms of antimicrobial resistance (AMR) among E coli causing UTIs in dogs in Western Canada during a 4-year surveillance period. ANIMALS: Urine from 516 dogs. METHODS: From November 2014 to 2018, 516 nonduplicate E coli isolates from the urine of dogs were collected from a diagnostic laboratory. Susceptibility testing was determined for a panel of 14 antimicrobials belonging to 7 drug classes. Resistant isolates were screened for the presence of extended-spectrum beta-lactamases (ESBLs), AmpC β-lactamases, and plasmid-mediated quinolone resistance (PMQR) genes. Epidemiological relationships were assessed by MLST. RESULTS: 80.2% (414/516) of isolates were susceptible to all antimicrobials tested. There was no significant increase in the proportion of isolates resistant to any of the tested antimicrobials during the study period. Resistance to ampicillin was the most common (14.9%, 77/516). Overall, 12 isolates had bla-type AmpC β-lactamases, and 7 produced CTX-M-type ESBLs. A single isolate had the aac(6')-Ib-cr PMQR gene. The qnr and qepA determinants were not detected. A single isolate belonging to the pandemic lineage ST131 was identified. CONCLUSION: Escherichia coli isolated from the urine of dogs in our region remain susceptible to first-line therapies, though resistance, particularly to the aminopenicillins, warrants monitoring. This is the first description of E coli ST131 from a companion animal in Canada.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33751667/